Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone-a case study approach
Related Experiment Video
Updated: Aug 14, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
1Immunohematology Research Laboratory, American Red Cross Blood Services, Southern California Region, 1130 South Vermont Avenue, Los Angeles, CA 90006, USA. arndtp@usa.redcross.org
Abstract:
In the 1970s, the most common causes of drug-induced immune hemolytic anemia were methyldopa and penicillin. Since 1990, the most common causes of drug-induced immune hemolytic anemia have been the second- and third-generation cephalosporins, cefotetan and ceftriaxone. Three case histories illustrate the common findings in the serologic investigation of immune hemolytic anemias due to these two drugs.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Therapeutic Drug Monitoring: Affecting Factors
Urine Studies II: Urine Culture and Sensitivity Test

